Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Background: Some risk classifications to determine prognosis of patients with non-muscle invasive bladder cancer (NMIBC) have disadvantages in the clinical setting. We investigated whether the EORTC (European Organization for Research and Treatment of Cancer) risk stratification is useful to predict...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Takeshi Ieda, M.D., Ph.D., Satoru Muto, M.D., Ph.D., Fumitaka Shimizu, M.D., Ph.D., Masataka Taguri, M.D., Ph.D., Shigeto Yanada, M.D., Kousuke Kitamura, M.D., Ph.D., Kazutaka Terai, M.D., Ph.D., Keisuke Saito, M.D., Ph.D., Tatsuya Ogishima, M.D., Ph.D., Masayoshi Nagata, M.D., Ph.D., Hisamitsu Ide, M.D., Ph.D., Takatsugu Okegawa, M.D., Ph.D., Yoshiaki Wakumoto, M.D., Ph.D., Yoshiro Sakamoto, M.D., Ph.D., Akira Tsujimura, M.D., Ph.D., Raizo Yamaguchi, M.D., Ph.D., Kikuo Nutahara, M.D., Shigeo Horie, M.D.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2016-10-01
Saila:	EBioMedicine
Gaiak:	Non-muscle invasive bladder cancer Recurrence Risk factor Classification
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2352396416304054
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!